社会决定因素与肿瘤生物学与早期激素依赖性乳腺癌生存种族差异的关联
该回顾性中介分析利用SEER-Oncotype登记数据,纳入60137例ER阳性、腋窝淋巴结阴性早期乳腺癌女性(黑人5648例,白人54489例),评估社会决定因素与肿瘤生物学对黑人-白人乳腺癌生存差异的贡献。中位随访56个月,黑人女性乳腺癌死亡年龄调整HR为1.82(95%CI 1.51-2.20);邻里劣势与保险状态共同中介19%的差异,肿瘤生物学特征中介20%,全调整模型中介44%。
要点
- 黑人女性乳腺癌死亡风险高于白人女性,年龄调整HR为1.82(95%CI 1.51-2.20)。
- 邻里劣势与保险状态共同中介19%的生存种族差异,肿瘤生物学特征中介20%。
- 全调整模型中介44%的生存种族差异,邻里劣势中介8%的高危复发评分概率差异。
核心结论
- 社会决定因素与包括基因组生物标志物在内的侵袭性肿瘤生物学指标,与早期ER阳性乳腺癌生存种族差异的关联程度相当。
研究设计与样本
- 回顾性中介分析,使用SEER-Oncotype登记数据,纳入2004年至2015年诊断、随访至2016年的病例。
- 纳入SEER-18登记中诊断时年龄≥18岁、首发原发性浸润性乳腺癌、腋窝淋巴结阴性且ER阳性、有21基因乳腺癌复发评分的黑人及非西班牙裔白人女性。
- 共纳入60137例女性,平均(IQR)年龄58.1(50-66)岁,其中黑人5648例(9.4%),白人54489例(90.6%)。
- 数据分析时间为2021年3月4日至2022年11月15日。
主要发现
- 中位(IQR)随访56(32-86)个月,黑人相比白人女性的乳腺癌死亡年龄调整HR为1.82(95%CI 1.51-2.20)。
- 邻里劣势与保险状态共同中介19%的差异(中介HR 1.62;95%CI 1.31-2.00;P < .001)。
- 肿瘤生物学特征中介20%的差异(中介HR 1.56;95%CI 1.28-1.90;P < .001)。
- 包含所有协变量的全调整模型中介44%的种族差异(中介HR 1.38;95%CI 1.11-1.71;P < .001)。
- 邻里劣势中介高危复发评分概率种族差异的8%(P = .02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
- 作者在结论中指出,未来研究应检查更全面的社会生态劣势测量、黑人女性侵袭性肿瘤生物学的分子机制以及祖先相关遗传变异的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Black women with hormone receptor-positive breast cancer experience the greatest racial disparity in survival of all breast cancer subtypes. The relative contributions of social determinants of health and tumor biology to this disparity are uncertain. OBJECTIVE: To determine the proportion of the Black-White disparity in breast cancer survival from estrogen receptor (ER)-positive, axillary node-negative breast cancer that is associated with adverse social determinants and high-risk tumor biology. DESIGN, SETTING, AND PARTICIPANTS: A retrospective mediation analysis of factors associated with the racial disparity in breast cancer death for cases diagnosed between 2004 and 2015 with follow-up through 2016 was carried out using the Surveillance, Epidemiology, and End Results (SEER) Oncotype registry. The study included women in the SEER-18 registry who were aged 18 years or older at diagnosis of a first primary invasive breast cancer tumor that was axillary node-negative and ER-positive, who were Black (Black), non-Hispanic White (White), and for whom the 21-gene breast recurrence score was available. Data analysis took place between March 4, 2021, and November 15, 2022. EXPOSURES: Census tract socioeconomic disadvantage, insurance status, tumor characteristics including the recurrence score, and treatment variables. MAIN OUTCOMES AND MEASURES: Death due to breast cancer. RESULTS: The analysis with 60 137 women (mean [IQR] age 58.1 [50-66] years) included 5648 (9.4%) Black women and 54 489 (90.6%) White women. With a median (IQR) follow-up time of 56 (32-86) months, the age-adjusted hazard ratio (HR) for breast cancer death among Black compared with White women was 1.82 (95% CI, 1.51-2.20). Neighborhood disadvantage and insurance status together mediated 19% of the disparity (mediated HR, 1.62; 95% CI, 1.31-2.00; P < .001) and tumor biological characteristics mediated 20% (mediated HR, 1.56; 95% CI, 1.28-1.90; P < .001). A fully adjusted model that included all covariates accounted for 44% of the racial disparity (mediated HR, 1.38; 95% CI, 1.11-1.71; P < .001). Neighborhood disadvantage mediated 8% of the racial difference in the probability of a high-risk recurrence score (P = .02). CONCLUSIONS AND RELEVANCE: In this study, racial differences in social determinants of health and indicators of aggressive tumor biology including a genomic biomarker were equally associated with the survival disparity in early-stage, ER-positive breast cancer among US women. Future research should examine more comprehensive measures of socioecological disadvantage, molecular mechanisms underlying aggressive tumor biology among Black women, and the role of ancestry-related genetic variants.
引用
- Hoskins KF, Calip GS, Huang HC, et al. Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer. JAMA Oncol. 2023. PMID: 36795405. doi:10.1001/jamaoncol.2022.7705
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。